A Pune centre led by an orthopaedic surgeon offering stem cell therapy for neurological and orthopaedic conditions including autism, cerebral palsy and spinal cord injury.
Chaitanya Stem Cell Center is a private centre in Pune, India, at CTS 1420 near Shaniwar Wada in Kasba Peth. It publishes three Indian mobile numbers and an international patients page, and the site states the centre has been working in stem cell therapy for fourteen years.
Its medical director is Dr Anant Bagul, an orthopaedic surgeon. The site says he qualified in medicine in 1986 and took a master of surgery in orthopaedics at B J Medical College, has thirty-three years of clinical experience, introduced Ilizarov external fixation surgery to Pune after training in France, and was principal investigator on a stem cell trial in acute spinal cord injury with Reliance Life Sciences in 2009. The site refers to a wider team of full-time and visiting consultants but does not name them.
On cell sources the site is only partly specific. Its autism page states that umbilical cord mesenchymal cells and bone marrow cells are used, given as a series of doses; the medical director's page refers instead to autologous — the patient's own — bone marrow derived cells. The two descriptions are not the same thing, and the site does not reconcile them or set out a protocol, so a prospective patient would need to establish exactly which is used.
The conditions listed are mainly neurological and orthopaedic: autism, cerebral palsy, spinal cord injury, avascular necrosis, muscular dystrophy, motor neurone disease, stroke, retinitis pigmentosa and chronic kidney disease. Several claims on the site deserve caution and are reported here as the site's own, unverified: it advertises a price of 99,000 rupees for stem cell treatment, states that more than 16,000 patients have been treated, and refers to 'FDA-approved technology' and insurance approval, none of which is substantiated on the pages read. Its autism page carries patient testimonials describing rapid improvement after treatment while also acknowledging that stem cell therapy for autism remains under research — a tension readers should weigh carefully.
The site names the following conditions; its autism page acknowledges that stem cell therapy for that diagnosis remains under research.
The site states that umbilical cord mesenchymal cells and bone marrow cells are used, though a separate page refers instead to the patient's own bone marrow derived cells.
The site names one clinician and refers to further full-time and visiting consultants without naming them.
The centre is at CTS 1420 near Shaniwar Wada in Kasba Peth, central Pune, and the site also describes a connection to Universal Hospital in Pune through its medical director. It runs an international patients service and states that it is ISO certified, though it does not name the certifying body or the scope of the certification. No laboratory is described on the pages read.
Unusually for this directory, the site advertises a figure: stem cell treatment at 99,000 Indian rupees. It does not say what that figure covers, whether it is per dose or per course, or what else a patient would pay for, so it should be treated as an advertised starting point rather than a total cost.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.